Omnicell Other Non-Current Liabilities 2010-2025 | OMCL
Omnicell other non-current liabilities from 2010 to 2025. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
| Omnicell Annual Other Non-Current Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $7 |
| 2023 | $6 |
| 2022 | $7 |
| 2021 | $8 |
| 2020 | $19 |
| 2019 | $12 |
| 2018 | $10 |
| 2017 | $10 |
| 2016 | $8 |
| 2015 | $12 |
| 2014 | $7 |
| 2013 | $5 |
| 2012 | $5 |
| 2011 | $1 |
| 2010 | $1 |
| 2009 | $1 |
| Omnicell Quarterly Other Non-Current Liabilities (Millions of US $) |
|
|---|---|
| 2024-12-31 | $7 |
| 2024-09-30 | $8 |
| 2024-06-30 | $8 |
| 2024-03-31 | $7 |
| 2023-12-31 | $6 |
| 2023-09-30 | $6 |
| 2023-06-30 | $6 |
| 2023-03-31 | $6 |
| 2022-12-31 | $7 |
| 2022-09-30 | $9 |
| 2022-06-30 | $9 |
| 2022-03-31 | $7 |
| 2021-12-31 | $8 |
| 2021-09-30 | $11 |
| 2021-06-30 | $19 |
| 2021-03-31 | $19 |
| 2020-12-31 | $19 |
| 2020-09-30 | $20 |
| 2020-06-30 | $16 |
| 2020-03-31 | $12 |
| 2019-12-31 | $12 |
| 2019-09-30 | $10 |
| 2019-06-30 | $10 |
| 2019-03-31 | $10 |
| 2018-12-31 | $10 |
| 2018-09-30 | $10 |
| 2018-06-30 | $11 |
| 2018-03-31 | $9 |
| 2017-12-31 | $10 |
| 2017-09-30 | $10 |
| 2017-06-30 | $10 |
| 2017-03-31 | $9 |
| 2016-12-31 | $8 |
| 2016-09-30 | $12 |
| 2016-06-30 | $12 |
| 2016-03-31 | $12 |
| 2015-12-31 | $12 |
| 2015-09-30 | $12 |
| 2015-06-30 | $12 |
| 2015-03-31 | $6 |
| 2014-12-31 | $7 |
| 2014-09-30 | $6 |
| 2014-06-30 | $6 |
| 2014-03-31 | $5 |
| 2013-12-31 | $5 |
| 2013-09-30 | $5 |
| 2013-06-30 | $5 |
| 2013-03-31 | $5 |
| 2012-12-31 | $5 |
| 2012-09-30 | $6 |
| 2012-06-30 | $3 |
| 2012-03-31 | $2 |
| 2011-12-31 | $1 |
| 2011-09-30 | $1 |
| 2011-06-30 | $1 |
| 2011-03-31 | $1 |
| 2010-12-31 | $1 |
| 2010-09-30 | $1 |
| 2010-06-30 | $1 |
| 2010-03-31 | $1 |
| 2009-12-31 | $1 |
| 2009-09-30 | $1 |
| 2009-06-30 | $1 |
| 2009-03-31 | $1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.202B | $1.112B |
| Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $37.877B | 52.32 |
| Hims & Hers Health (HIMS) | United States | $10.991B | 115.05 |
| Tempus AI (TEM) | United States | $8.988B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.774B | 74.60 |
| IRhythm Technologies (IRTC) | United States | $4.316B | 0.00 |
| Privia Health (PRVA) | United States | $2.756B | 206.54 |
| Enovis (ENOV) | United States | $1.947B | 12.05 |
| Schrodinger (SDGR) | United States | $1.721B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.712B | 0.00 |
| Phreesia (PHR) | United States | $1.426B | 0.00 |
| Azenta (AZTA) | United States | $1.162B | 54.08 |
| 10x Genomics (TXG) | United States | $0.991B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.573B | 0.00 |
| Talkspace (TALK) | United States | $0.530B | 157.25 |
| Butterfly Network (BFLY) | United States | $0.527B | 0.00 |
| Veradigm (MDRX) | United States | $0.486B | 0.00 |
| Standard BioTools (LAB) | United States | $0.403B | 0.00 |
| TruBridge (TBRG) | United States | $0.381B | 0.00 |
| Claritev (CTEV) | United States | $0.329B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.286B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.218B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.200B | 0.00 |
| Pulmonx (LUNG) | United States | $0.138B | 0.00 |
| American Well (AMWL) | United States | $0.106B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.095B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.092B | 0.00 |
| CareCloud (CCLD) | United States | $0.091B | 3.45 |
| MDxHealth SA (MDXH) | Belgium | $0.080B | 0.00 |
| 111 (YI) | China | $0.069B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.063B | 0.00 |
| HeartBeam (BEAT) | United States | $0.062B | 0.00 |
| Outset Medical (OM) | United States | $0.041B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.040B | 0.00 |
| Zhongchao (ZCMD) | China | $0.033B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |